Plus, underuse of aspirin after stent is “a travesty” says Mayo doctor Cardiologists were urged to halt the "epidemic of madness" behind drug-eluting stent (DES) overuse, during an address by Salim Yusuf, M.D., McMaster University, Hamilton, Ontario, at the World Congress of Cardiology in Barcelona.
Positive six-month results of Abbott's SPIRIT II clinical trial of the XIENCE V Everolimus Eluting Coronary Stent System were presented at the World Congress of Cardiology conference in Barcelona, Spain. XIENCE V, which has received CE Mark approval, is currently an investigational device in the U.S. and Japan — Abbott says it plans to initiate European launch of the coronary DES in October.
Thousands of lives potentially saved and hospital costs reduced are the predicted outcomes if more hospitals adopt certain quality measures on a wider scale, according to an analysis by Premier Inc. healthcare alliance, headquartered in San Diego, which is owned by more than 200 of the nation's leading not-for-profit hospitals and healthcare systems.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
It may seem like a simple concept, but the importance of properly controlled patient temperature is still surprising ...
Abiomed Inc. recently announced the start of the IMPELLA 2.5 pilot study in the U.S. with the enrollment of the first ...
A software fusion application that enables clinicians to perform multimodality image fusion in a single application ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
OXILAN (Ioxilan Injection) is a contrast media for use in peripheral procedures because of its viscosity. Its reportedly ...
At a pivotal time of advancement in cardiovascular imaging, diagnostics, interventions and therapies, a time when specialty heart hospitals are forming to combat the deadliest disease in America, the federal purse strings are about to be pulled a little tighter in 2007, and rules for these types of narrowly focused hospitals are going to be more stringent.
While enormous pressure may be the norm for cardiac surgeons, the stakes are particularly high when the life of a former U.S. president is on the line. And when Bill Clinton underwent quadruple bypass surgery in 2004, all eyes were on the heart specialists at NewYork-Presbyterian Hospital in New York City.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The Relay 250-mm thoracic stent-graft is commercially available in Europe in both straight and taper configurations. The ...
The EXCOR TAH-t has received CE approval with the CardioWest TAH-t. The pneumatic drivers provide precisely calibrated ...
The Philips integrated cath lab is a solution featuring integrated technologies designed to improve productivity and throughput.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Targeted Renal Therapy (TRT) with the Benephit CV Infusion System from FlowMedica Inc. is an alternative to systemic intravenous (IV) infusion of medications to address kidney dysfunction related to a number of conditions. TRT is a novel technology that enables the infusion of medications and other therapeutic agents directly into the kidneys via the renal arteries.
The Atlas II ICD (implantable cardioverter defibrillator) and Atlas II HF CRT-D (cardiac resynchronization therapy defibrillator) devices are capable of delivering unsurpassed energy, giving added security to patients whose hearts are especially difficult to defibrillate.
The i-STAT BNP cartridge is a point of care diagnostic test used to assess the level of BNP (brain naturietic peptide) ...